clinical trial · NCT03527069
Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment
EMS·phase3·completed·n = 146
HypertriglyceridemiaDyslipidemiaCipros 10 associationCrestor 10 mg
brief summary
The purpose of this study is to evaluate the efficacy of Cipros 10 association in the treatment of Dyslipidemia Treatment
started
Jan 29, 2021
primary completion
Aug 30, 2024
completion
Jul 25, 2025
last updated
Dec 8, 2025
official title
Phase III, National, Multicenter, Randomized, Double Blind Clinical Trial, to Evaluate the Efficacy and Safety of Cipros 10 Association on Dyslipidemia Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol